Health Populi

MARCH 3, 2021

Those issues were COVID-19, the 2020 Election, health care policy, racial divides, and equity and access. W2O notes that these five issues became more-inter-related than ever, compared with previous years’ top consumer health issues. These ten are all life science/pharma companies.

Life Science 170

Life Science Public Health Primary Care Patient Experience 170

Health Populi

APRIL 21, 2021

Those “waves of demand” TripleTree described will impact every segment of care delivery and sponsor, including small to mid-sized physician practices, employers, behavioral/mental health, public/government-sponsored health care programs, and the pharma and life science industry.

Telehealth 380

Telehealth Public Health Life Science Primary Care 380

Healthcare IT Today

JUNE 15, 2023

Non-health insurers and life sciences companies also recognize the value of clinical data and are requiring greater levels of access to power their applications and processes. Here is one example of how payer exchange is being automated today. Connections are built with health plans to receive requests electronically.

Life Science 79

Life Science Health Information EHR Leadership 79

Health Populi

MARCH 28, 2022

For example, say you opt into the insulin resistance protocol. For many years, I’ve advocated for siloes to break down so that these organizations, all of which have mission statements that speak to benefit patient care and health outcomes, to more effective reach those Holy Grails.

Life Science 279

Life Science mHealth Primary Care Pharmaceuticals 279

Health Populi

MARCH 9, 2022

.” I was particularly keen to dig into this study based on its sponsoring organization: JLL is a real estate services company serving over a dozen vertical markets — including health care, life sciences, senior housing, and retail, among other industry sectors.

Telehealth 227

Telehealth Medicare Life Science Mental health 227

Health Populi

JUNE 24, 2021

In the larger public and population health context, on the patient side, we can expect the burden of disease beyond COVID to increase due to postponed care and treatment backlogs. for example, for heart disease and cardiovascular complications as well as for cancers. This has been found to be the case in the U.S.,

BioTech 270

BioTech Pharmaceuticals Public Health Telehealth 270

Health Populi

FEBRUARY 2, 2021

. “We” was a trio including Antoinette Thomas (@NurseTechExec1), Chief Patient Experience Officer with Microsoft, David Ryan (@DavidPRyan), former long-time Global Head of Intel’s Health/Life Science business; and, me.

Telemedicine 156

Telemedicine Public Health Life Science Remote care 156